Literature DB >> 8500245

Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group.

R F Smith1, G Johnson, S Ziesche, G Bhat, K Blankenship, J N Cohn.   

Abstract

BACKGROUND: Left ventricular (LV) dysfunction plays a primary role in the pathogenesis of congestive heart failure and correlates with prognosis, but a strong quantitative relation between exercise performance and indexes of LV function has not been demonstrated. We examined the relation between LV ejection fraction at rest, oxygen consumption at peak exercise (VO2), patient and physician assessments of clinical severity, and other clinical attributes in 804 patients with moderate heart failure. METHODS AND
RESULTS: Ejection fraction correlated weakly with VO2, and mean ejection fraction was related to severity of symptoms. There was a statistical association between the patient's self-assessed quality of life questionnaire score and the physician-assigned New York Heart Association (NYHA) functional class; NYHA class was statistically associated with exercise performance. To identify other factors that might influence exercise capacity, comparisons of clinical attributes were made between patients grouped by VO2 within each stratum of LV function. Exercise performance was inversely related to plasma norepinephrine levels within the ejection fraction < 25% stratum. The percentage of patients reaching their anaerobic threshold was not different between groups, yet the peak heart rate increased with VO2 within all strata. Elevated venous pressure and cardiomegaly were inversely related to exercise performance.
CONCLUSIONS: Clinical scales based on physician and patient assessment of symptoms were statistically associated with exercise capacity but do not accurately predict individual exercise performance. The strong association of heart rate response to exercise performance suggests that the variability of the chronotropic response to exercise contributes to differences in exercise capacity among patients with a similar degree of LV dysfunction.

Entities:  

Mesh:

Year:  1993        PMID: 8500245

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure.

Authors:  Stuart D Katz; Haoyi Zheng
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 2.  Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure.

Authors:  Carlo Rostagno; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2008-02-26       Impact factor: 3.397

3.  Heart rate variability in patients with the first and recurrent myocardial infarction.

Authors:  T Ristimäe; H V Huikuri; R Teesalu
Journal:  Clin Auton Res       Date:  1998-08       Impact factor: 4.435

Review 4.  Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.

Authors:  J N Cohn
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

5.  Clinical and echocardiographic correlates of health status in patients with acute chest pain.

Authors:  K E Fleischmann; R T Lee; P C Come; L Goldman; K M Kuntz; P A Johnson; M A Weissman; T H Lee
Journal:  J Gen Intern Med       Date:  1997-12       Impact factor: 5.128

6.  The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients.

Authors:  Robert A Carels
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

7.  The influence of exercise tolerance on quality of life among patients with heart failure.

Authors:  Chii Jeng; Mei-Hsing Yang; Pao-Lo Chen; Chiung-Hua Ho
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

8.  Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression.

Authors:  Marion Schowalter; Götz Gelbrich; Stefan Störk; Jan-Philip Langguth; Caroline Morbach; Georg Ertl; Hermann Faller; Christiane E Angermann
Journal:  Clin Res Cardiol       Date:  2012-12-21       Impact factor: 5.460

9.  Resting muscle sympathetic nerve activity, cardiac metaiodobenzylguanidine uptake, and exercise tolerance in patients with left ventricular dysfunction.

Authors:  Masue Yoh; Fumio Yuasa; Jun Mimura; Hiroshi Yokoe; Akihiro Kawamura; Tetsuro Sugiura; Toshiji Iwasaka
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

10.  A Critical Reappraisal of the Current Clinical Indications to Cardiac Resynchronisation Therapy.

Authors:  Antonio Sorgente; Riccardo Cappato
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.